Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/20867Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Zervoudis, S. | en |
| dc.contributor.author | Peitsidis, P. | en |
| dc.contributor.author | Iatrakis, G. | en |
| dc.contributor.author | Panourgias, E. | en |
| dc.contributor.author | Koureas, A. | en |
| dc.contributor.author | Navrozoglou, I. | en |
| dc.contributor.author | Dubois, J. B. | en |
| dc.date.accessioned | 2015-11-24T19:10:46Z | - |
| dc.date.available | 2015-11-24T19:10:46Z | - |
| dc.identifier.issn | 1107-0625 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/20867 | - |
| dc.rights | Default Licence | - |
| dc.subject | Breast Neoplasms/*diagnosis/pathology | en |
| dc.subject | False Positive Reactions | en |
| dc.subject | Female | en |
| dc.subject | Follow-Up Studies | en |
| dc.subject | Humans | en |
| dc.subject | Neoplasm Metastasis | en |
| dc.subject | Neoplasm Recurrence, Local/*diagnosis | en |
| dc.subject | Neoplasm Staging | en |
| dc.subject | Tumor Markers, Biological/*blood | en |
| dc.title | Increased levels of tumor markers in the follow-up of 400 patients with breast cancer without recurrence or metastasis: interpretation of false-positive results | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/18067207 | - |
| heal.language | en | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 2007 | - |
| heal.abstract | PURPOSE: To analyze, study and interpret the increased levels of tumor markers in breast cancer patients without recurrence or metastasis. PATIENTS AND METHODS: We studied a series of 400 patients with stage 1 breast cancer during a 3-year follow-up after primary treatment. Follow-up included frequent serum estimation of CEA, CA 15.3, CA 125, CA 27-29, TPA and TPS tumor markers. RESULTS: Of 358 patients being continuously disease-free, 18 (5%) cases showed false-positive levels of tumor markers, associated with benign conditions and not to cancer recurrence or metastasis. These conditions included ovarian cysts, thyroid disorders, hepatitis, renal stone and sarcoidosis. CONCLUSION: The value of increased tumor markers should be interpreted cautiously because it doesn't always imply disease recurrence. Tumor markers may increase in many benign conditions. | en |
| heal.journalName | J BUON | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
